PAFAH1B3 and neoplasm: Studies have shown that PAFAH1B3 is highly expressed in breast cancer14, osteosarcoma31, hypopharyngeal squamous cell carcinoma32 and multiple myeloma33 and is a poor prognostic factor in tumours.